Otonomy (OTIC) – Hot Corp. News
-
Otonomy (OTIC) Says Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus Demonstrated No Clinically Meaningful Benefit Versus Placebo
-
Otonomy (OTIC) Phase 3 Clinical Trial of OTIVIDEX in Patients with Meniere's Disease Did Not Achieve Primary Endpoint
-
-
-
-
-
Back to OTIC Stock Lookup